Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects.
A new study, carried out at six hospitals across the UK, tracked 625 men with prostate cancer who received a type of treatment called high-intensity focused ultrasound (HIFU).
The research, published in the journal European Urology, is the largest ever study of HIFU treatment used to target prostate tumours. The treatment is similar to a ‘lumpectomy’ for other cancers – where doctors remove only tumour cells, leaving as much healthy tissue as possible.
The findings, from a number of institutions including Imperial College London, Imperial College Healthcare Trust and University College London, found that after five years the cancer survival rate from HIFU was 100 per cent. Approximately, 1 in 10 men needed further treatment. The cancer survival rate from surgery and radiotherapy is also 100 per cent at five years.
This latest trial of focal HIFU…suggests we may be able to tackle the cancer with fewer side effectsProfessor Hashim AhmedLead author
The research also showed the risk of side effects of HIFU, such as urinary incontinence and erectile dysfunction, were lower than other treatment options, at 2 per cent and 15 per cent respectively.
Professor Hashim Ahmed, lead author from the Department of Surgery and Cancer at Imperial, said: “Although prostate cancer survival rates are now very good, the side effects of surgery or radiotherapy can be life-changing. Some patients are left requiring multiple incontinence pads every day, or with severe erectile dysfunction.”
He added: “We need to now focus on improving the quality of life for these men following treatment. This latest trial of focal HIFU – which is the largest and longest study of the treatment to date – suggests we may be able to tackle the cancer with fewer side effects.”
Prostate cancer is the most common cancer in men in the UK, with around 47,000 cases every year.
Treatments include surgery to remove the gland, or radiotherapy, which uses radiation to the entire prostate.
However, these treatments can cause collateral damage to surrounding sensitive tissues like nerves, muscles, urine passage, bladder and rectum. The prostate is roughly the size of a walnut and sits between the bladder and the penis.
Surgery and radiotherapy to the entire prostate are effective treatments but can lead to long term risk of urinary problems, like incontinence, of between 5-30 per cent. They also carry a risk of erectile dysfunction of between 30-60 per cent. Radiotherapy can also cause rectal problems like bleeding, diarrhoea and discomfort in 5 per cent of patients.
HIFU is a newer treatment, performed under general anaesthetic, which delivers beams of high energy ultrasound directly into the prostate gland, via a probe inserted up the back passage. There are no needles or cuts to skin. This allows a surgeon to precisely target tumour cells within the gland to millimetre accuracy, with less risk of damage to surrounding tissues.
In the new HIFU study, conducted on men with an average age of 65 and whose cancer hadn’t spread, the risk of urine incontinence (defined as requiring pad use) at five years after the treatment was 2 per cent, and the risk of erectile dysfunction 15 per cent. The team say the results include patients with medium to high risk cancer.
The scientists also tracked the number of patients who needed further treatment following HIFU, (such as surgery or radiotherapy), to treat any cancer cells that had returned. They found 10 per cent of patients needed further treatment by five years, which is comparable to number of patients needing further treatment after surgery or radiotherapy (5-15 per cent).
The treatment was over in a day…I’m closely monitored by my GP, and so far the cancer has not returned – Anthony Murland, Patient
The team add that prostate cancer patients should talk through all possible treatments with their healthcare team, so they can consider their options fully.
Further follow-up trials are needed to track progress of the patients after ten years, as well as trials that directly compare HIFU with surgery and radiotherapy.
Dr Caroline Moore, Reader in Urology from the UCL Faculty of Medical Sciences said: “The registry based data from over 600 men is very encouraging. We started the HIFU programme at UCLH in 2003, and now principally use it as a focal treatment, where we treat the cancer but not the entire prostate.
This means that men are much more likely to preserve urinary and sexual function, compared to traditional surgery or radiotherapy. Focal treatment is particularly suitable for men who have prostate cancer visible on MRI, which is contained to one area of the prostate.”
Anthony Murland underwent HIFU treatment in November last year at Imperial College Healthcare NHS Trust to treat his prostate cancer. “I first heard of the treatment from a friend, who had the procedure a few months before. My GP hadn’t heard of HIFU, but was very interested, so I ended up educating him about it. He then referred me for the treatment on the NHS” explained the 67-year-old from Suffolk.
“I liked the sound of the treatment as it seemed the least invasive option, with low risk. The treatment was over in a day – I went in first thing in the morning and was out by the evening. I didn’t have any pain, but needed a catheter for five days, which was a bit uncomfortable.
“I’m closely monitored by my GP, and so far the cancer has not returned.”
The Latest on: Prostate cancer
via Google News
The Latest on: Prostate cancer
- Oncotarget: Drug-resistant cells grow exponentially in metastatic prostate canceron January 25, 2021 at 4:03 am
The Oncotarget authors show that the drug-resistant, metastasis-causing cells are capable of producing drug-resistant, exponentially growing tumors, responsible for tumor growth as a patient receives ...
- Mediterranean Diet Might Benefit Low-Risk Prostate Cancer Patientson January 22, 2021 at 11:09 am
A recent study from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer on active surveillance might benefit from following a Mediterranean-style diet.
- This AI can tell if you have prostate cancer by looking at your peeon January 21, 2021 at 10:51 am
Researchers at the Korean Institute of Science and Technology (KIST) recently developed a machine for detecting prostate cancer that only needs 20 minutes of your time and a few ounces of your pee to ...
- Coffee Tied to Lower Risk of Prostate Canceron January 21, 2021 at 2:00 am
Drinking coffee may lower the risk for prostate cancer. Researchers combined data from 16 prospective studies that calculated the risk associated with the highest versus the lowest coffee consumption.
- New technique can rapidly diagnose prostate cancer from urineon January 20, 2021 at 11:25 pm
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on PSA, a cancer factor in blood.
- Prostate Cancer Diagnostics Market Statistics, Size, Share, Regional Analysis by Key Players | Industry Forecast to 2027on January 20, 2021 at 4:44 am
Rising incidences of prostate cancer is one of the significant factors influencing the growth of the diagnostic procedures for the disease. Market Size ...
- New tests may help improve the selection of men considering prostate cancer surveillanceon January 17, 2021 at 5:13 am
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
- New clues to prostate canceron January 16, 2021 at 12:58 pm
New research has identified a new mechanism in which prostate cancer cells can 'switch' character and become resistant to therapy. These findings are an important development in unraveling how an ...
- Artificial intelligence tool for reading MRI scans could transform prostate cancer surgery and treatmenton January 15, 2021 at 6:17 am
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict ...
via Bing News